This comprehensive assessment evaluates your visual acuity, ocular structure, and environmental strain factors. Accurate answers ensure personalized insights and recommendations.
Preferred Name
Date of Birth
Gender Identity
Female
Male
Non-binary
Prefer not to say
Prefer to self-describe:
Primary Occupation
Student
Office/Desk Worker
Healthcare Professional
Education/Teaching
Retail/Service
Manufacturing/Production
Transportation/Driver
Remote Worker
Retired
Other:
Total Daily Screen Time (hours)
Do you use blue-light filtering software or hardware?
Rate how clearly you see at various distances under normal lighting.
Rate your vision clarity (without correction) for each scenario
Very Poor | Poor | Fair | Good | Excellent | |
|---|---|---|---|---|---|
Distance vision (driving, watching TV) | |||||
Intermediate vision (computer work) | |||||
Near vision (reading, phone) | |||||
Night vision (driving after dark) | |||||
Vision in bright sunlight |
Do you currently wear vision correction?
When did you last update your prescription?
Within 6 months
6–12 months ago
1–2 years ago
Over 2 years
Never had an exam
How satisfied are you with your current correction?
Very Dissatisfied
Dissatisfied
Neutral
Satisfied
Very Satisfied
Do you experience double vision (diplopia)?
Rate the frequency of these symptoms in the past month
Never | Rarely | Sometimes | Often | Constantly | |
|---|---|---|---|---|---|
Dryness or gritty sensation | |||||
Burning or stinging | |||||
Excessive watering | |||||
Redness | |||||
Eyelid crusting or flaking | |||||
Foreign-body sensation |
Do you use eye drops or artificial tears?
Never
Occasionally (≤2×/week)
Frequently (3–6×/week)
Daily
Multiple times daily
Have you been diagnosed with dry-eye disease?
Do you experience seasonal eye allergies?
Describe any triggers or patterns you notice (e.g., air-conditioning, pollen, contact-lens wear)
Prolonged screen use can cause digital eye strain. Evaluate your habits and symptoms.
Rate how often you experience these during or after screen use
Never | Rarely | Sometimes | Often | Always | |
|---|---|---|---|---|---|
Eyestrain or fatigue | |||||
Headache behind eyes | |||||
Blurred vision when looking away | |||||
Neck or shoulder pain | |||||
Difficulty refocusing |
How far is your primary screen from your eyes?
<40 cm
40–60 cm
60–80 cm
>80 cm
Varies frequently
How often do you take visual breaks (20-20-20 rule)?
Never
Rarely
Sometimes
Often
Always
Do you use dark-mode or night-mode settings?
Ambient lighting while working
Dim
Moderate
Bright
Glare present
Variable
Average air-humidity in your workspace (%) if known
Have you ever had eye surgery?
Have you ever had an eye injury?
Select any diagnosed eye conditions
Myopia (nearsightedness)
Hyperopia (farsightedness)
Astigmatism
Presbyopia
Amblyopia (lazy eye)
Strabismus (crossed eyes)
Glaucoma
Cataract
Age-related macular degeneration
Diabetic retinopathy
Retinal detachment
Keratoconus
None of the above
Select any systemic conditions that can affect eyes
Diabetes (Type 1)
Diabetes (Type 2)
Hypertension
Autoimmune disease (lupus, RA, etc.)
Thyroid disease
Multiple sclerosis
Migraine
High cholesterol
None of the above
Do you take medications that may affect vision?
Many eye conditions have hereditary components. Provide family history to the best of your knowledge.
Any other familial eye disorders or blindness?
Ethnic background (relevant for risk profiling)
How would you rate your overall diet?
Very Poor
Poor
Fair
Good
Excellent
How often do you consume these eye-healthy foods?
Leafy greens (spinach, kale) 2×/week
Oily fish (salmon, mackerel) 2×/week
Citrus fruits daily
Nuts/seeds 4×/week
Carrots/sweet potato 2×/week
Eggs 3×/week
Do you take supplements for eye health?
No
Multivitamin
Vitamin A
Lutein/zeaxanthin
Omega-3
AREDS-2 formula
Combination
Other:
Smoking status
Never smoked
Former smoker
Current smoker
Vaping/e-cigarettes
Average nightly sleep duration
<5 hours
5–6 hours
6–7 hours
7–8 hours
>8 hours
Do you routinely wear sunglasses outdoors?
Do you use safety eyewear for sports or work?
Indicate how much eye-related symptoms interfere with daily activities.
Rate the level of interference
None | Mild | Moderate | Severe | Unable to perform | |
|---|---|---|---|---|---|
Reading for work/study | |||||
Driving (daytime) | |||||
Driving (nighttime) | |||||
Computer/phone use | |||||
Watching TV | |||||
Outdoor activities | |||||
Social interactions | |||||
Sleep quality |
Overall eye comfort this week (1 = worst, 10 = best)
Have symptoms caused you to miss work/school in the past month?
Are you filling this form for a child <18 years?
Yes
No
Did the child pass newborn eye screening?
Any eye rubbing or squinting observed?
Family history of childhood glasses?
When did you last see an eye-care professional?
Within 1 year
1–2 years ago
2–5 years ago
Over 5 years
Never
Would you like reminders for regular eye exams?
Preferred mode of eye-care reminders
SMS
App notification
Phone call
Not needed
Are you interested in vision-correction surgery?
Any questions or concerns you would like addressed at your next visit?
I certify that the information provided is accurate to the best of my knowledge. I understand this assessment is informational and not a substitute for professional eye examination.
I agree to the above statement
Signature
Analysis for Comprehensive Visual & Ocular Health Assessment
Important Note: This analysis provides strategic insights to help you get the most from your form's submission data for powerful follow-up actions and better outcomes. Please remove this content before publishing the form to the public.
This Comprehensive Visual & Ocular Health Assessment is one of the most complete patient-reported eye-health instruments available online. It marries clinical rigor with consumer-friendly language, ensuring high-quality data while keeping abandonment low. The form’s progressive disclosure (conditional follow-ups) reduces cognitive load, and the matrix-style questions collapse what could have been 30+ separate items into a few easy-to-scan grids. From a data-collection perspective, it captures the full continuum of visual function (acuity, comfort, strain, lifestyle, genetics) rather than isolated symptoms, allowing predictive risk-scoring for conditions such as digital-eye-strain-induced myopia progression or early dry-eye disease.
Privacy is handled pragmatically: no free-text field is mandatory beyond a preferred name, and sensitive items (ethnicity, gender identity, medications) are optional or self-describe, mitigating GDPR/HIPAA friction. The inclusion of both subjective ratings and objective habits (screen distance, humidity, supplement brands) creates a dataset that clinicians can triage before the patient ever enters the exam lane. Finally, the form’s responsive structure—grouping questions into intuitive domains—mirrors the flow of a live ophthalmic history, shortening provider chair time and increasing diagnostic yield.
Asking for a preferred rather than legal name is a small but powerful UX choice; it respects trans, non-binary, and multicultural users while still giving clinicians a reliable handle for charting and reminder messages. Because it is short and familiar, it lowers the psychological barrier to starting the form.
From a data-quality standpoint, a free-text single-line field captures nicknames, initials, or westernised names that a dropdown could never enumerate. This improves match rates when the same patient returns for follow-up assessments or is imported into an EHR under a different legal name.
The placeholder “e.g., Alexandra Chen” subtly signals that the form is global and inclusive, not just for Anglo-Saxon names. This micro-copy reduces blank-field drop-off by setting clear expectations without resorting to legal jargon.
Age is the single strongest predictor for most ocular pathologies—presbyopia, cataract, AMD, glaucoma—so capturing DOB is non-negotiable for risk stratification. The date-picker prevents format ambiguity (MM/DD vs. DD/MM) and automatically calculates exact age for algorithms.
Because DOB is personally identifiable, the form pairs it with a privacy-oriented consent section, reinforcing transparency. Optional questions later (ethnicity, family history) can then be linked to age-adjusted risk curves, producing personalised advice such as “Your AMD risk is 3× higher than average for your age and ethnicity.”
Making DOB mandatory also enables paediatric branching logic: if the calculated age is <18, the form surfaces the “Pediatric & Developmental History” section, ensuring developmental red flags are not missed while keeping the adult path clean.
Screen time is a proxy for accommodative stress and blue-light exposure, both of which correlate with dry-eye complaints and myopic shift in young adults. By asking for a single numeric value, the form balances precision with user burden; most respondents can estimate to the nearest hour without a stopwatch.
The numeric validation prevents alphabetic noise and outliers (>24 h) at the point of entry, improving downstream analytics. When paired with the follow-up question on blue-light filters, clinicians can triage whether a patient’s asthenopia is environmental or truly pathological.
Longitudinally, this field enables population-level surveillance: cohorts reporting >10 h/day can be flagged for early intervention, driving revenue for preventive blue-light coatings, specialised lenses, or lifestyle counselling services.
Matrix questions dramatically reduce click fatigue—here, five functional distances are rated on one screen. The Likert scale anchors (“Very Poor” to “Excellent”) are symmetrical and include mid-point “Fair,” minimising central-tendency bias.
By specifying “without correction,” the form isolates the eye’s native optics, giving clinicians a baseline to compare against refraction data. This is critical for detecting undiagnosed myopia progression in teenagers who may still pass school vision screenings with squinting.
The inclusion of both night vision and bright-sunlight vision captures mesopic and photopic extremes, surfacing early cataract or macular dysfunction that might be missed in a well-lit exam room. When these ratings diverge from Snellen acuity, it triggers further diagnostic work-up.
Dry-eye disease has a 30% prevalence in office workers, yet remains under-diagnosed because symptoms fluctuate. Anchoring the recall period to “the past month” improves reliability versus “recently” or “ever.”
The six-item symptom set covers the DEQ-5 core (dryness, grittiness, watering) plus signs (redness, crusting) that suggest blepharitis or allergic conjunctivitis. This breadth allows the algorithm to subtype the patient’s ocular surface disease and recommend targeted therapies (warm compresses vs. antihistamines vs. prescription cyclosporine).
Because the scale is frequency-based (“Never” to “Constantly”), it can be summed into a severity index that correlates with TBUT and Schirmer scores, giving clinicians a validated patient-reported outcome that tracks treatment efficacy over time.
Informed consent is legally compulsory for any self-assessment that generates health advice. Rendering it as a checkbox rather than a buried “continue” button satisfies both FTC and medical-board guidelines for digital health tools.
The adjacent paragraph clarifies that the assessment is “informational and not a substitute for professional eye examination,” reducing liability while encouraging appropriate follow-up. Users cannot proceed without checking the box, ensuring enforceability.
Pairing the consent checkbox with an optional signature field future-proofs the form for tele-health integration, where a digital signature may be required to prescribe or refer.
Mandatory Question Analysis for Visual & Ocular Health Assessment
Important Note: This analysis provides strategic insights to help you get the most from your form's submission data for powerful follow-up actions and better outcomes. Please remove this content before publishing the form to the public.
Preferred Name
Justification: A human-readable identifier is the linchpin for personalised reports, reminder campaigns, and follow-up visits. Without it, the system cannot address the user in emails (“Hi Alex, your last assessment was…”), which dramatically reduces engagement and re-conversion rates. Because the field is short and culturally flexible, keeping it mandatory adds negligible friction while safeguarding data integrity.
Date of Birth
DOB drives every age-adjusted risk model in ophthalmology—from glaucoma screening starting at 40, to AMD surveillance after 55. It also powers paediatric logic branching, ensuring that children <18 receive the developmental section. Omitting DOB would render the clinical algorithm blind to the strongest predictor of ocular disease incidence, making the entire assessment clinically unreliable.
Total Daily Screen Time (hours)
This metric is the cornerstone for digital-eye-strain scoring and blue-light exposure estimation. Because the form delivers tailored advice (“Your 12 h/day places you in the 95th percentile; consider the 20-20-20 rule”), leaving it blank would trigger generic, low-value recommendations. Mandatory capture ensures the AI can correlate hours of accommodation with symptom severity, maintaining the scientific credibility of the report.
Checkbox: I agree to the above statement
Regulatory bodies require explicit, auditable consent before storing or analysing health data. A mandatory checkbox creates a timestamped event that satisfies HIPAA, GDPR, and most medical-board standards for digital health tools. Without it, the platform risks legal exposure and cannot ethically process the user’s responses.
The form adopts a minimal-mandatory philosophy: only four out of 80+ fields are compulsory. This keeps completion rates high while still collecting the non-negotiable data needed for clinical risk scoring and regulatory compliance. To further optimise, consider making “Total Daily Screen Time” conditionally mandatory only if the user reports any digital-strain symptom above “Sometimes”; this reduces burden for low-risk respondents while preserving data richness for symptomatic users.
For future iterations, evaluate whether “Primary Occupation” should move from optional to mandatory when screen time >8 h/day, because occupational visual demands (e.g., CAD designer vs. ride-share driver) modify ergonomic advice. Conversely, consider demoting DOB to optional for anonymous population-survey modes, but keep it mandatory in clinical or referral pathways. Finally, add real-time micro-copy that explains why a field is required (“We need your age to calculate cataract risk”), which has been shown to increase willing disclosure by 18–25% in health-assessment contexts.